Will Morton[email protected]Molecular ImagingPET/MRI can reduce the need for biopsies in prostate cancerProstate biopsies are associated with considerable morbidity, including pain, rectal bleeding, prostatitis, and urinary tract infections.July 2, 2026Digital X-RaySocioeconomic conditions amplify pollution-related bone lossThe findings underscore how environmental and social conditions work together to influence long-term bone health.July 1, 2026Molecular ImagingPET/CT guides treatment in men with recurrent prostate cancerF-18 fluciclovine and Ga-68 PSMA-11 PET/CT have similar benefits for sRT planning, in terms of improving cancer control without increased toxicity.June 30, 2026CTHospital resources tied to AI adoption for stroke detectionNTAP-billed AI use was most common in episodes with CT imaging, at comprehensive stroke centers, and in facilities with ≥1000 beds.June 26, 2026Interventional'Supermajority' emerges among interventional radiologistsThe percentage of those with a super-majority (>90%) of IR-related work more than doubled between 2008 and 2023.June 26, 2026CTSocioeconomic factors shape lung cancer screening burdenDifferences in patient experience were closely linked to social and economic factors.June 25, 2026MRICardiac MRI variables boost heart failure predictionSixteen key cardiac MRI variables improved risk prediction.June 23, 2026Molecular ImagingNew PET tracer shows promise for guiding pancreatic cancer therapyThe radiotracer is designed to identify pancreatic tumors eligible for paired therapy with cancer-killing actinium-225 (Ac-225) NMT25.June 19, 2026Digital X-RayPrunes not likely to improve bone health in menThe findings are contrary to similar studies in women.June 16, 2026Nuclear MedicineNew immuno-PET tracer shows promise in prostate cancerCompared to conventional imaging, Zr-89 DFO-YS5 PET identified additional lesions.June 15, 2026Previous PagePage 2 of 56Next PageTop StoriesCTCT radiation doses have fallen sharply over past decadeThe largest reductions appeared in chest examinations with contrast material, where diagnostic reference levels fell 31%.BreastCEM finds breast cancer at baseline, incidence screeningMRIPodcast: Testing the effectiveness of today's MR safety standard of careWomens ImagingUterine fibroid assessment differs by imaging techniqueMRISocieties host events for MR Safety Week
